Back to top

Image: Bigstock

3 Reasons Momentum Stock Investors Will Love Cross Country (CCRN)

Read MoreHide Full Article

Many investors like to look for momentum in stocks, but this can be very tough to define. There is great debate regarding which metrics are the best to focus on in this regard, and which are not really quality indicators of future performance. Fortunately, with our new style score system we have identified the key statistics to pay close attention to and thus which stocks might be the best for momentum investors in the near term.

This method discovered several great candidates for momentum-oriented investors, but today let’s focus in on Cross Country Healthcare, Inc. (CCRN - Free Report) as this stock is looking especially impressive right now. And while there are numerous ways in which this company could be a great choice, we have highlighted three of the most vital reasons for CCRN’s status as a solid momentum stock below:

Short Term Price Change for Cross Country

A great place to look for finding momentum stocks is by inspecting short term price activity. This can help to reflect the current interest in a stock and if buyers or sellers have the upper hand right now. It is especially useful to compare it to the industry as this can help investors pinpoint the top companies in a particular area.

CROSS COUNTRY Price and Consensus
 

CROSS COUNTRY Price and Consensus | CROSS COUNTRY Quote

With a one week price change of 27.4% compared to an industry average of 2.1%, CCRN is certainly well-positioned in this regard. The stock is also looking quite well from a longer time frame too, as the four week price change compares favorably with the industry at large as well.

Quarter EPS Estimate Change for Cross Country Stock

While looking at price performance or full year earnings can be essential to understanding a momentum stock, you shouldn’t forget about the current quarter EPS and the trend in estimates there. This change can signal how a stock might perform in the next earnings season which is obviously vital for momentum investors.

Right now, CCRN is seeing a nice trend over the past month when it comes to this quarter’s earnings estimate projections. In the time frame, EPS estimates for Cross Country have gone up by 10.7% compared to an industry average move of -4%, suggesting that not only is CCRN heading in the right direction, but it is seeing an increase relative to the industry too.

CCRN Earnings Estimate Revisions Moving in the Right Direction

While the great momentum factors outlined in the preceding paragraphs might be enough for some investors, we should also take into account broad earnings estimate revision trends. A nice path here can really help to show us a promising stock, and we have actually been seeing that with CCRN as of late too.

Over the past two months, 3 earnings estimates have gone higher compared to no downward revisions for the full year, while we are also seeing 3 upward revisions with no downward revisions for the next year time frame too.  These revisions have helped to boost the consensus estimate as two months ago CCRN was expected to post earnings of 58 cents /share for the full year, though today it looks to have EPS of 68 cents per share for the full year now, representing a solid increase which is something that should definitely be welcomed news to would-be investors.

Bottom Line

Given these factors, investors shouldn’t be surprised to note that we have CCRN as a security with a Zacks Rank #2 (Buy) and a Momentum Score of ‘A’.  You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So if you are looking for a fresh pick that has potential to move in the right direction, definitely keep CCRN on your short list as this looks be a stock that is very well-positioned to soar in the near term.

The Best Place to Start Your Stock Search

Today, you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 ""Strong Buy"" stocks – absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 ""Strong Sells"" and other private research. See these stocks free >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Cross Country Healthcare, Inc. (CCRN) - free report >>

Published in